BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

7.28
Delayed Data
As of Sep 21
 -0.03 / -0.41%
Today’s Change
4.12
Today|||52-Week Range
8.13
+48.27%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close7.31
Today’s open7.28
Day’s range7.19 - 7.56
Volume1,978,555
Average volume (3 months)786,681
Market cap$786.4M
Data as of 4:00pm ET, 09/21/2018

Growth & Valuation

Earnings growth (last year)-4.00%
Earnings growth (this year)-15.24%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-4.43%
P/E ratioNM
Price/Sales16.46
Price/Book8.55

Competitors

 Today’s
change
Today’s
% change
URGNUrogen Pharma Ltd+0.78+1.60%
FATEFate Therapeutics In...+0.54+3.85%
FIXXHomology Medicines I...+1.16+5.68%
RDUSRadius Health Inc-0.90-4.78%
Data as of 4:00pm ET, 09/21/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$25.2M
Annual profit (last year)-$65.8M
Net profit margin-261.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts